Catalio Capital Management
Catalio Capital Management

Catalio Capital Management

DR31Ahrefs DR: 31/100. Below median. Measured by Ahrefs. Median 44.

Website
2020Venture Capital9 portfolioUnited States

About

Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or referred by Catalio Capital Management, an elite group of world-renowned, serial scientist-entrepreneurs.

Key facts

At-a-glance profile data

Website
cataliocapital.com
Type
Venture Capital
Headquarters
United States
Portfolio companies
9
Stages
Series A
Series E
Series F
Strategic
Cheque size
$38M to $239M
Sector focus
Healthcare
Immunology
Data
Analytics
Personalized Treatment

Recent investments

Recent funding rounds Catalio Capital Management took part in
DateCompanyRoundAmount
18 Jun 2024InsightecSeries F$150M
2 May 2023Enveda BiosciencesUndisclosed round$50M
25 Jan 2022Enveda BiosciencesUndisclosed round$51M
11 Feb 2021ImmunaiSeries A$60M
Add first review

Frequently asked

What companies has Catalio Capital Management invested in?

Catalio Capital Management has invested in Insightec, Enveda Biosciences, Immunai, Recursion Pharmaceuticals, ProSomnus and 4 more.